These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 26189209)

  • 1. EEG alpha asymmetry as a gender-specific predictor of outcome to acute treatment with different antidepressant medications in the randomized iSPOT-D study.
    Arns M; Bruder G; Hegerl U; Spooner C; Palmer DM; Etkin A; Fallahpour K; Gatt JM; Hirshberg L; Gordon E
    Clin Neurophysiol; 2016 Jan; 127(1):509-519. PubMed ID: 26189209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability of frontal alpha asymmetry in depressed patients during antidepressant treatment.
    van der Vinne N; Vollebregt MA; van Putten MJAM; Arns M
    Neuroimage Clin; 2019; 24():102056. PubMed ID: 31795035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frontal and rostral anterior cingulate (rACC) theta EEG in depression: implications for treatment outcome?
    Arns M; Etkin A; Hegerl U; Williams LM; DeBattista C; Palmer DM; Fitzgerald PB; Harris A; deBeuss R; Gordon E
    Eur Neuropsychopharmacol; 2015 Aug; 25(8):1190-200. PubMed ID: 25936227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of event-related potentials in predicting antidepressant treatment response: An iSPOT-D report.
    van Dinteren R; Arns M; Kenemans L; Jongsma ML; Kessels RP; Fitzgerald P; Fallahpour K; Debattista C; Gordon E; Williams LM
    Eur Neuropsychopharmacol; 2015 Nov; 25(11):1981-90. PubMed ID: 26282359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EEG Abnormalities Are Associated With Poorer Depressive Symptom Outcomes With Escitalopram and Venlafaxine-XR, but Not Sertraline: Results From the Multicenter Randomized iSPOT-D Study.
    Arns M; Gordon E; Boutros NN
    Clin EEG Neurosci; 2017 Jan; 48(1):33-40. PubMed ID: 26674366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normalization of EEG in depression after antidepressant treatment with sertraline? A preliminary report.
    van der Vinne N; Vollebregt MA; Boutros NN; Fallahpour K; van Putten MJAM; Arns M
    J Affect Disord; 2019 Dec; 259():67-72. PubMed ID: 31437703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amygdala Reactivity to Emotional Faces in the Prediction of General and Medication-Specific Responses to Antidepressant Treatment in the Randomized iSPOT-D Trial.
    Williams LM; Korgaonkar MS; Song YC; Paton R; Eagles S; Goldstein-Piekarski A; Grieve SM; Harris AW; Usherwood T; Etkin A
    Neuropsychopharmacology; 2015 Sep; 40(10):2398-408. PubMed ID: 25824424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frontoparietal Activation During Response Inhibition Predicts Remission to Antidepressants in Patients With Major Depression.
    Gyurak A; Patenaude B; Korgaonkar MS; Grieve SM; Williams LM; Etkin A
    Biol Psychiatry; 2016 Feb; 79(4):274-81. PubMed ID: 25891220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. International Study to Predict Optimized Treatment for Depression (iSPOT-D), a randomized clinical trial: rationale and protocol.
    Williams LM; Rush AJ; Koslow SH; Wisniewski SR; Cooper NJ; Nemeroff CB; Schatzberg AF; Gordon E
    Trials; 2011 Jan; 12():4. PubMed ID: 21208417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a Machine Learning Model Based on Pretreatment Symptoms and Electroencephalographic Features to Predict Outcomes of Antidepressant Treatment in Adults With Depression: A Prespecified Secondary Analysis of a Randomized Clinical Trial.
    Rajpurkar P; Yang J; Dass N; Vale V; Keller AS; Irvin J; Taylor Z; Basu S; Ng A; Williams LM
    JAMA Netw Open; 2020 Jun; 3(6):e206653. PubMed ID: 32568399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Childhood trauma predicts antidepressant response in adults with major depression: data from the randomized international study to predict optimized treatment for depression.
    Williams LM; Debattista C; Duchemin AM; Schatzberg AF; Nemeroff CB
    Transl Psychiatry; 2016 May; 6(5):e799. PubMed ID: 27138798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CNS- and ANS-arousal predict response to antidepressant medication: Findings from the randomized iSPOT-D study.
    Olbrich S; Tränkner A; Surova G; Gevirtz R; Gordon E; Hegerl U; Arns M
    J Psychiatr Res; 2016 Feb; 73():108-15. PubMed ID: 26714202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EEG connectivity between the subgenual anterior cingulate and prefrontal cortices in response to antidepressant medication.
    Iseger TA; Korgaonkar MS; Kenemans JL; Grieve SM; Baeken C; Fitzgerald PB; Arns M
    Eur Neuropsychopharmacol; 2017 Apr; 27(4):301-312. PubMed ID: 28237506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic Resonance Imaging Measures of Brain Structure to Predict Antidepressant Treatment Outcome in Major Depressive Disorder.
    Korgaonkar MS; Rekshan W; Gordon E; Rush AJ; Williams LM; Blasey C; Grieve SM
    EBioMedicine; 2015 Jan; 2(1):37-45. PubMed ID: 26137532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The international Study to Predict Optimized Treatment in Depression (iSPOT-D): outcomes from the acute phase of antidepressant treatment.
    Saveanu R; Etkin A; Duchemin AM; Goldstein-Piekarski A; Gyurak A; Debattista C; Schatzberg AF; Sood S; Day CV; Palmer DM; Rekshan WR; Gordon E; Rush AJ; Williams LM
    J Psychiatr Res; 2015 Feb; 61():1-12. PubMed ID: 25586212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretreatment qEEG biomarkers for predicting pharmacological treatment outcome in major depressive disorder: Independent validation from the NeuroPharm study.
    Ip CT; Olbrich S; Ganz M; Ozenne B; Köhler-Forsberg K; Dam VH; Beniczky S; Jørgensen MB; Frokjaer VG; Søgaard B; Christensen SR; Knudsen GM
    Eur Neuropsychopharmacol; 2021 Aug; 49():101-112. PubMed ID: 33910154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain imaging predictors and the international study to predict optimized treatment for depression: study protocol for a randomized controlled trial.
    Grieve SM; Korgaonkar MS; Etkin A; Harris A; Koslow SH; Wisniewski S; Schatzberg AF; Nemeroff CB; Gordon E; Williams LM
    Trials; 2013 Jul; 14():224. PubMed ID: 23866851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cognitive-emotional biomarker for predicting remission with antidepressant medications: a report from the iSPOT-D trial.
    Etkin A; Patenaude B; Song YJ; Usherwood T; Rekshan W; Schatzberg AF; Rush AJ; Williams LM
    Neuropsychopharmacology; 2015 May; 40(6):1332-42. PubMed ID: 25547711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychomotor retardation is linked to frontal alpha asymmetry in major depression.
    Cantisani A; Koenig T; Horn H; Müller T; Strik W; Walther S
    J Affect Disord; 2015 Dec; 188():167-72. PubMed ID: 26363266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Antidepressant Treatment Response Index as a Predictor of Reboxetine Treatment Outcome in Major Depressive Disorder.
    Caudill MM; Hunter AM; Cook IA; Leuchter AF
    Clin EEG Neurosci; 2015 Oct; 46(4):277-84. PubMed ID: 25258429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.